| pubmed-article:20949133 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C0021368 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C0039215 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C0674428 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C1667052 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C0439662 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
| pubmed-article:20949133 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:20949133 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:20949133 | pubmed:dateCreated | 2010-10-15 | lld:pubmed |
| pubmed-article:20949133 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:abstractText | Maraviroc treatment for HIV-1 infected patients results in larger CD4(+) T cell rises than are attributable to its antiviral activity alone. We investigated whether this is due to modulation of T cell activation and inflammation. | lld:pubmed |
| pubmed-article:20949133 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20949133 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20949133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20949133 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20949133 | pubmed:issn | 1932-6203 | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:ValdezHernanH | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:LedermanMicha... | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:RajicicNatasa... | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:EasonJamesJ | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:GoodrichJames... | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:MayerHowardH | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:KalinowskaMag... | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:FunderburgNic... | lld:pubmed |
| pubmed-article:20949133 | pubmed:author | pubmed-author:HeeraJayvantJ | lld:pubmed |
| pubmed-article:20949133 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20949133 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:20949133 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20949133 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20949133 | pubmed:pagination | e13188 | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:meshHeading | pubmed-meshheading:20949133... | lld:pubmed |
| pubmed-article:20949133 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20949133 | pubmed:articleTitle | Effects of maraviroc and efavirenz on markers of immune activation and inflammation and associations with CD4+ cell rises in HIV-infected patients. | lld:pubmed |
| pubmed-article:20949133 | pubmed:affiliation | Case Western Reserve University, Cleveland, Ohio, United States of America. | lld:pubmed |
| pubmed-article:20949133 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20949133 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20949133 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
